Julian Vance

Intermittent fasting does not automatically cost muscle mass, but protein intake, training, and deficit size matter more than the eating window alone.

Home blood pressure monitoring can clarify risk and treatment response, but cuff fit, technique, averages, and clinical context decide what it means.

Metabolic syndrome can flag clustered cardiometabolic risk, but it needs context, repeatable habits, and medical caution rather than a one-size-fits-all fix.

Prediabetes is a useful warning signal, but not a diagnosis with a countdown. Here is what the evidence says about risk, testing, and limits.

CGMs can reveal glucose patterns, but for adults without diabetes the evidence is early, noisy, and not a stand-alone reason to change diet.

A post-meal walk can blunt glucose rises for some adults, but timing, meal size, medicines, and diabetes risk all change what the evidence means.

Time-restricted eating may help some adults reduce intake and improve markers, but trials suggest meal timing is not a metabolic shortcut for health.

A cautious evidence-led look at what a 72-hour fast changes, where the human data are thin, and who should avoid fasting without medical care.

Autophagy is real cellular housekeeping, but fasting claims often run ahead of human evidence. Here is what the science can and cannot say safely.

Intermittent fasting can structure eating windows, but benefits mostly track energy intake. This beginner guide weighs protocols, evidence, and safety limits.